Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8516 |
High Similarity |
NPD5760 |
Phase 2 |
0.8516 |
High Similarity |
NPD5761 |
Phase 2 |
0.8494 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.8092 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.787 |
Intermediate Similarity |
NPD6764 |
Approved |
0.787 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7688 |
Intermediate Similarity |
NPD6785 |
Approved |
0.7688 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7588 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7531 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.744 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7391 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7386 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7344 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7239 |
Intermediate Similarity |
NPD920 |
Approved |
0.7233 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD919 |
Approved |
0.7186 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD37 |
Approved |
0.7126 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7117 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7108 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7107 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7101 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7101 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7101 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7101 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7088 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7074 |
Intermediate Similarity |
NPD7497 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7059 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7048 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7044 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7041 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7035 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7018 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6983 |
Remote Similarity |
NPD8312 |
Approved |
0.6983 |
Remote Similarity |
NPD8313 |
Approved |
0.6982 |
Remote Similarity |
NPD2801 |
Approved |
0.6981 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6981 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6975 |
Remote Similarity |
NPD3750 |
Approved |
0.6966 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6964 |
Remote Similarity |
NPD7411 |
Suspended |
0.6957 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6949 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6946 |
Remote Similarity |
NPD3226 |
Approved |
0.6944 |
Remote Similarity |
NPD8407 |
Phase 2 |
0.6941 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD2796 |
Approved |
0.6937 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6933 |
Remote Similarity |
NPD6190 |
Approved |
0.6932 |
Remote Similarity |
NPD7228 |
Approved |
0.6928 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD5403 |
Approved |
0.6914 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD1243 |
Approved |
0.6914 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.691 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD5401 |
Approved |
0.6909 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6894 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6894 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6893 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6893 |
Remote Similarity |
NPD7054 |
Approved |
0.6886 |
Remote Similarity |
NPD7239 |
Suspended |
0.6882 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6882 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD3748 |
Approved |
0.6872 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6871 |
Remote Similarity |
NPD7003 |
Approved |
0.6868 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6867 |
Remote Similarity |
NPD17 |
Approved |
0.6859 |
Remote Similarity |
NPD7095 |
Approved |
0.6855 |
Remote Similarity |
NPD6653 |
Approved |
0.6854 |
Remote Similarity |
NPD7472 |
Approved |
0.6852 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6836 |
Remote Similarity |
NPD7799 |
Discontinued |
0.6836 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6836 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6835 |
Remote Similarity |
NPD4140 |
Approved |
0.6833 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6815 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD3764 |
Approved |
0.681 |
Remote Similarity |
NPD2800 |
Approved |
0.68 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6798 |
Remote Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.6795 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6793 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD230 |
Phase 1 |
0.679 |
Remote Similarity |
NPD2344 |
Approved |
0.679 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.679 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6778 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6778 |
Remote Similarity |
NPD7240 |
Approved |
0.6774 |
Remote Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.6772 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.677 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6768 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6761 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6755 |
Remote Similarity |
NPD1778 |
Approved |
0.6752 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6747 |
Remote Similarity |
NPD1511 |
Approved |
0.6743 |
Remote Similarity |
NPD6959 |
Discontinued |
0.674 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6732 |
Remote Similarity |
NPD3972 |
Approved |
0.673 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6728 |
Remote Similarity |
NPD2438 |
Suspended |
0.6727 |
Remote Similarity |
NPD2354 |
Approved |
0.6727 |
Remote Similarity |
NPD3887 |
Approved |
0.6723 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6723 |
Remote Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.6722 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6719 |
Remote Similarity |
NPD7435 |
Discontinued |
0.671 |
Remote Similarity |
NPD2797 |
Approved |
0.6709 |
Remote Similarity |
NPD3268 |
Approved |
0.6709 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6708 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6707 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD447 |
Suspended |
0.6687 |
Remote Similarity |
NPD5735 |
Approved |
0.6667 |
Remote Similarity |
NPD6385 |
Approved |
0.6667 |
Remote Similarity |
NPD3057 |
Approved |
0.6667 |
Remote Similarity |
NPD1512 |
Approved |
0.6667 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD6386 |
Approved |
0.6649 |
Remote Similarity |
NPD4107 |
Approved |
0.6648 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6647 |
Remote Similarity |
NPD5353 |
Approved |
0.6646 |
Remote Similarity |
NPD4534 |
Discontinued |
0.6646 |
Remote Similarity |
NPD1607 |
Approved |
0.6646 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6645 |
Remote Similarity |
NPD1283 |
Approved |
0.6627 |
Remote Similarity |
NPD2309 |
Approved |
0.6625 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6625 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6625 |
Remote Similarity |
NPD1240 |
Approved |
0.6624 |
Remote Similarity |
NPD9494 |
Approved |
0.6623 |
Remote Similarity |
NPD9545 |
Approved |
0.6613 |
Remote Similarity |
NPD8360 |
Approved |
0.6613 |
Remote Similarity |
NPD8361 |
Approved |
0.6613 |
Remote Similarity |
NPD8435 |
Approved |
0.661 |
Remote Similarity |
NPD5710 |
Approved |
0.661 |
Remote Similarity |
NPD5711 |
Approved |
0.661 |
Remote Similarity |
NPD7315 |
Approved |
0.6608 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6604 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6604 |
Remote Similarity |
NPD7985 |
Registered |
0.6584 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6584 |
Remote Similarity |
NPD4665 |
Approved |
0.6584 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6584 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6584 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.658 |
Remote Similarity |
NPD2972 |
Approved |
0.658 |
Remote Similarity |
NPD3533 |
Approved |
0.6579
|
Remote Similarity |
NPD5585 |
Approved |